FDA Approves First Generic Naloxone Nasal Spray Against Opioid Overdose

FRIDAY, April 19, 2019 -- The first generic naloxone nasal spray to treat opioid overdose has received approval from the U.S. Food and Drug Administration. Teva Pharmaceuticals ' lifesaving product is also the first generic naloxone nasal spray...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news